HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Irregular anti-P1 allo-antibodies and sinensis clonorchiasis].

Abstract
A parasitological and immuno-hematological study was undertaken simultaneously in fifty South-East asian refugees at the time of their arrival in France. --in this series the frequency of individuals having a P2 erythrocyte phenotype is 80%. --54 % of these immigrants were found to be carriers of Clonorchis sinensis, a parasite rarely found in Europe. --in 40,7 % of these subjects infested by Clonorchis sinensis, the following properties were disclosed concerning the P1 allo-antibody: slow-P1 red cell agglutination at 22 degrees C, no hemolysis of P1 red cells in vitro, IgM antibody, in weak titers. The immuno-hematological study of the immuno-serums with respect to distomian antigens coupled with adsorption-elution using P1+++ red cells shows a close immunological relationship between the antibody of parasite origin and the anti-P1 allo-antibody.
AuthorsA Petit, T H Duong, J L Bremond, A Barrabes, C Binet, C Combescot, M E Leroux
JournalRevue francaise de transfusion et immuno-hematologie (Rev Fr Transfus Immunohematol) Vol. 24 Issue 2 Pg. 197-210 (Apr 1981) ISSN: 0338-4535 [Print] France
Vernacular TitleAllo-anticorps irréguliers anti-P1 et clonorchiase á Clonorchis sinensis.
PMID7027412 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Anthelmintics
  • Antibodies
  • Blood Group Antigens
  • Isoantibodies
  • P Blood-Group System
  • Mebendazole
  • flubendazole
Topics
  • Anthelmintics (therapeutic use)
  • Antibodies (immunology)
  • Blood Group Antigens (immunology)
  • Clonorchiasis (blood, drug therapy)
  • Clonorchis sinensis (immunology)
  • Humans
  • Immunoelectrophoresis
  • Isoantibodies (immunology)
  • Mebendazole (analogs & derivatives, therapeutic use)
  • P Blood-Group System (genetics, immunology)
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: